RBM9 anticorps (N-Term)
Aperçu rapide pour RBM9 anticorps (N-Term) (ABIN633399)
Antigène
Voir toutes RBM9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- RBM9 antibody was raised against the N terminal of RBM9
-
Purification
- Affinity purified
-
Immunogène
- RBM9 antibody was raised using the N terminal of RBM9 corresponding to a region with amino acids STQAHGEQSSNSPSTQNGSLTTEGGAQTDGQQSQTQSSENSESKSTPKRL
-
-
-
-
Indications d'application
-
WB: 0.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RBM9 Blocking Peptide, (ABIN5615799), is also available for use as a blocking control in assays to test for specificity of this RBM9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RBM9 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RBM9 (RNA Binding Motif Protein 9 (RBM9))
-
Autre désignation
- RBM9
-
Sujet
- RBM9 is a RNA-binding protein that seems to act as a coregulatory factor of ER-alpha. This gene is one of several human genes similar to the C. elegans gene Fox-1. This gene encodes an RNA binding protein that is thought to be a key regulator of alternative exon splicing in the nervous system and other cell types.
-
Poids moléculaire
- 40 kDa (MW of target protein)
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Skeletal Muscle Fiber Development
Antigène
-